 | • レポートコード：MRC22NVL19296 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年の経口溶解フィルム製剤の成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界の経口溶解フィルム製剤市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界の経口溶解フィルム製剤市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国の経口溶解フィルム製剤市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の経口溶解フィルム製剤市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の経口溶解フィルム製剤の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要な経口溶解フィルム製剤プレーヤーとして、GSK、 LTS、 J&J、 Indivior、 Pfizer、 Sanofi、 Church & Dwight、 tesa Labtec、 Tapemark、 Prestige、 Sun Pharma、 MonoSol、 BioDelivery、 Arx、 ZIM、 NAL Pharma、 AdhexPharma、 Aavishkar、 IntelGenx Corp、 APRなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとの経口溶解フィルム製剤市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 口腔内崩壊性フィルム、口腔粘膜付着性フィルム 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 病院、ドラッグストア、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：経口溶解フィルム製剤の年間販売量2017-2028、地域別現状・将来分析 ・経口溶解フィルム製剤のタイプ別セグメント：口腔内崩壊性フィルム、口腔粘膜付着性フィルム ・経口溶解フィルム製剤のタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・経口溶解フィルム製剤の用途別セグメント：病院、ドラッグストア、その他 ・経口溶解フィルム製剤の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界の経口溶解フィルム製剤市場 ・企業別のグローバル経口溶解フィルム製剤市場データ：2020-2022年の年間販売量、市場シェア ・企業別の経口溶解フィルム製剤の年間売上：2020-2022年の売上、市場シェア ・企業別の経口溶解フィルム製剤販売価格 ・主要企業の経口溶解フィルム製剤生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 経口溶解フィルム製剤の地域別レビュー ・地域別の経口溶解フィルム製剤市場規模2017-2022：年間販売量、売上 ・主要国別の経口溶解フィルム製剤市場規模2017-2022：年間販売量、売上 ・南北アメリカの経口溶解フィルム製剤販売の成長 ・アジア太平洋の経口溶解フィルム製剤販売の成長 ・欧州の経口溶解フィルム製剤販売の成長 ・中東・アフリカの経口溶解フィルム製剤販売の成長 南北アメリカ市場 ・南北アメリカの国別の経口溶解フィルム製剤販売量、売上（2017-2022） ・南北アメリカの経口溶解フィルム製剤の種類別販売量 ・南北アメリカの経口溶解フィルム製剤の用途別販売量 ・米国の経口溶解フィルム製剤市場 ・カナダの経口溶解フィルム製剤市場 ・メキシコの経口溶解フィルム製剤市場 ・ブラジルの経口溶解フィルム製剤市場 アジア太平洋市場 ・アジア太平洋の国別の経口溶解フィルム製剤販売量、売上（2017-2022） ・アジア太平洋の経口溶解フィルム製剤の種類別販売量 ・アジア太平洋の経口溶解フィルム製剤の用途別販売量 ・中国市場の経口溶解フィルム製剤市場 ・日本市場の経口溶解フィルム製剤市場 ・韓国市場の経口溶解フィルム製剤市場 ・東南アジアの経口溶解フィルム製剤市場 ・インドの経口溶解フィルム製剤市場 ・オーストラリアの経口溶解フィルム製剤市場 ・台湾の経口溶解フィルム製剤市場 欧州市場 ・欧州の国別の経口溶解フィルム製剤販売量、売上（2017-2022） ・欧州の経口溶解フィルム製剤の種類別販売量 ・欧州の経口溶解フィルム製剤の用途別販売量 ・ドイツの経口溶解フィルム製剤市場 ・フランスの経口溶解フィルム製剤市場 ・イギリスの経口溶解フィルム製剤市場 ・イタリアの経口溶解フィルム製剤市場 ・ロシアの経口溶解フィルム製剤市場 中東・アフリカ市場 ・中東・アフリカの国別の経口溶解フィルム製剤販売量、売上（2017-2022） ・中東・アフリカの経口溶解フィルム製剤の種類別販売量 ・中東・アフリカの経口溶解フィルム製剤の用途別販売量 ・エジプトの経口溶解フィルム製剤市場 ・南アフリカの経口溶解フィルム製剤市場 ・イスラエルの経口溶解フィルム製剤市場 ・トルコの経口溶解フィルム製剤市場 ・GCC諸国の経口溶解フィルム製剤市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・経口溶解フィルム製剤の製造コスト構造分析 ・経口溶解フィルム製剤の製造プロセス分析 ・経口溶解フィルム製剤の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・経口溶解フィルム製剤の主要なグローバル販売業者 ・経口溶解フィルム製剤の主要なグローバル顧客 地域別の経口溶解フィルム製剤市場予測レビュー ・地域別の経口溶解フィルム製剤市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・経口溶解フィルム製剤のタイプ別市場規模予測 ・経口溶解フィルム製剤の用途別市場規模予測 主要企業分析 GSK、 LTS、 J&J、 Indivior、 Pfizer、 Sanofi、 Church & Dwight、 tesa Labtec、 Tapemark、 Prestige、 Sun Pharma、 MonoSol、 BioDelivery、 Arx、 ZIM、 NAL Pharma、 AdhexPharma、 Aavishkar、 IntelGenx Corp、 APR ・企業情報 ・経口溶解フィルム製剤製品 ・経口溶解フィルム製剤販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Orally Dissolving Film Drug will have significant change from previous year. According to our (LP Information) latest study, the global Orally Dissolving Film Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Orally Dissolving Film Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Orally Dissolving Film Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Orally Dissolving Film Drug market, reaching US$ million by the year 2028. As for the Europe Orally Dissolving Film Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Orally Dissolving Film Drug players cover GSK, LTS, J&J, and Indivior, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Orally Dissolving Film Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Orodispersible Film
Oromucosal Film
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Drugstores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orally Dissolving Film Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Orally Dissolving Film Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Orally Dissolving Film Drug by Country/Region, 2017, 2022 & 2028
2.2 Orally Dissolving Film Drug Segment by Type
2.2.1 Orodispersible Film
2.2.2 Oromucosal Film
2.3 Orally Dissolving Film Drug Sales by Type
2.3.1 Global Orally Dissolving Film Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Orally Dissolving Film Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Orally Dissolving Film Drug Sale Price by Type (2017-2022)
2.4 Orally Dissolving Film Drug Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.4.3 Others
2.5 Orally Dissolving Film Drug Sales by Application
2.5.1 Global Orally Dissolving Film Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Orally Dissolving Film Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Orally Dissolving Film Drug Sale Price by Application (2017-2022)
3 Global Orally Dissolving Film Drug by Company
3.1 Global Orally Dissolving Film Drug Breakdown Data by Company
3.1.1 Global Orally Dissolving Film Drug Annual Sales by Company (2020-2022)
3.1.2 Global Orally Dissolving Film Drug Sales Market Share by Company (2020-2022)
3.2 Global Orally Dissolving Film Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Orally Dissolving Film Drug Revenue by Company (2020-2022)
3.2.2 Global Orally Dissolving Film Drug Revenue Market Share by Company (2020-2022)
3.3 Global Orally Dissolving Film Drug Sale Price by Company
3.4 Key Manufacturers Orally Dissolving Film Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orally Dissolving Film Drug Product Location Distribution
3.4.2 Players Orally Dissolving Film Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Orally Dissolving Film Drug by Geographic Region
4.1 World Historic Orally Dissolving Film Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Orally Dissolving Film Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Orally Dissolving Film Drug Annual Revenue by Geographic Region
4.2 World Historic Orally Dissolving Film Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Orally Dissolving Film Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Orally Dissolving Film Drug Annual Revenue by Country/Region
4.3 Americas Orally Dissolving Film Drug Sales Growth
4.4 APAC Orally Dissolving Film Drug Sales Growth
4.5 Europe Orally Dissolving Film Drug Sales Growth
4.6 Middle East & Africa Orally Dissolving Film Drug Sales Growth
5 Americas
5.1 Americas Orally Dissolving Film Drug Sales by Country
5.1.1 Americas Orally Dissolving Film Drug Sales by Country (2017-2022)
5.1.2 Americas Orally Dissolving Film Drug Revenue by Country (2017-2022)
5.2 Americas Orally Dissolving Film Drug Sales by Type
5.3 Americas Orally Dissolving Film Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orally Dissolving Film Drug Sales by Region
6.1.1 APAC Orally Dissolving Film Drug Sales by Region (2017-2022)
6.1.2 APAC Orally Dissolving Film Drug Revenue by Region (2017-2022)
6.2 APAC Orally Dissolving Film Drug Sales by Type
6.3 APAC Orally Dissolving Film Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Orally Dissolving Film Drug by Country
7.1.1 Europe Orally Dissolving Film Drug Sales by Country (2017-2022)
7.1.2 Europe Orally Dissolving Film Drug Revenue by Country (2017-2022)
7.2 Europe Orally Dissolving Film Drug Sales by Type
7.3 Europe Orally Dissolving Film Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Orally Dissolving Film Drug by Country
8.1.1 Middle East & Africa Orally Dissolving Film Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Orally Dissolving Film Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Orally Dissolving Film Drug Sales by Type
8.3 Middle East & Africa Orally Dissolving Film Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orally Dissolving Film Drug
10.3 Manufacturing Process Analysis of Orally Dissolving Film Drug
10.4 Industry Chain Structure of Orally Dissolving Film Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orally Dissolving Film Drug Distributors
11.3 Orally Dissolving Film Drug Customer
12 World Forecast Review for Orally Dissolving Film Drug by Geographic Region
12.1 Global Orally Dissolving Film Drug Market Size Forecast by Region
12.1.1 Global Orally Dissolving Film Drug Forecast by Region (2023-2028)
12.1.2 Global Orally Dissolving Film Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orally Dissolving Film Drug Forecast by Type
12.7 Global Orally Dissolving Film Drug Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Orally Dissolving Film Drug Product Offered
13.1.3 GSK Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 LTS
13.2.1 LTS Company Information
13.2.2 LTS Orally Dissolving Film Drug Product Offered
13.2.3 LTS Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 LTS Main Business Overview
13.2.5 LTS Latest Developments
13.3 J&J
13.3.1 J&J Company Information
13.3.2 J&J Orally Dissolving Film Drug Product Offered
13.3.3 J&J Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 J&J Main Business Overview
13.3.5 J&J Latest Developments
13.4 Indivior
13.4.1 Indivior Company Information
13.4.2 Indivior Orally Dissolving Film Drug Product Offered
13.4.3 Indivior Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Indivior Main Business Overview
13.4.5 Indivior Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Orally Dissolving Film Drug Product Offered
13.5.3 Pfizer Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi Orally Dissolving Film Drug Product Offered
13.6.3 Sanofi Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 Church & Dwight
13.7.1 Church & Dwight Company Information
13.7.2 Church & Dwight Orally Dissolving Film Drug Product Offered
13.7.3 Church & Dwight Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Church & Dwight Main Business Overview
13.7.5 Church & Dwight Latest Developments
13.8 tesa Labtec
13.8.1 tesa Labtec Company Information
13.8.2 tesa Labtec Orally Dissolving Film Drug Product Offered
13.8.3 tesa Labtec Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 tesa Labtec Main Business Overview
13.8.5 tesa Labtec Latest Developments
13.9 Tapemark
13.9.1 Tapemark Company Information
13.9.2 Tapemark Orally Dissolving Film Drug Product Offered
13.9.3 Tapemark Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Tapemark Main Business Overview
13.9.5 Tapemark Latest Developments
13.10 Prestige
13.10.1 Prestige Company Information
13.10.2 Prestige Orally Dissolving Film Drug Product Offered
13.10.3 Prestige Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Prestige Main Business Overview
13.10.5 Prestige Latest Developments
13.11 Sun Pharma
13.11.1 Sun Pharma Company Information
13.11.2 Sun Pharma Orally Dissolving Film Drug Product Offered
13.11.3 Sun Pharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sun Pharma Main Business Overview
13.11.5 Sun Pharma Latest Developments
13.12 MonoSol
13.12.1 MonoSol Company Information
13.12.2 MonoSol Orally Dissolving Film Drug Product Offered
13.12.3 MonoSol Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 MonoSol Main Business Overview
13.12.5 MonoSol Latest Developments
13.13 BioDelivery
13.13.1 BioDelivery Company Information
13.13.2 BioDelivery Orally Dissolving Film Drug Product Offered
13.13.3 BioDelivery Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 BioDelivery Main Business Overview
13.13.5 BioDelivery Latest Developments
13.14 Arx
13.14.1 Arx Company Information
13.14.2 Arx Orally Dissolving Film Drug Product Offered
13.14.3 Arx Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Arx Main Business Overview
13.14.5 Arx Latest Developments
13.15 ZIM
13.15.1 ZIM Company Information
13.15.2 ZIM Orally Dissolving Film Drug Product Offered
13.15.3 ZIM Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 ZIM Main Business Overview
13.15.5 ZIM Latest Developments
13.16 NAL Pharma
13.16.1 NAL Pharma Company Information
13.16.2 NAL Pharma Orally Dissolving Film Drug Product Offered
13.16.3 NAL Pharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 NAL Pharma Main Business Overview
13.16.5 NAL Pharma Latest Developments
13.17 AdhexPharma
13.17.1 AdhexPharma Company Information
13.17.2 AdhexPharma Orally Dissolving Film Drug Product Offered
13.17.3 AdhexPharma Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 AdhexPharma Main Business Overview
13.17.5 AdhexPharma Latest Developments
13.18 Aavishkar
13.18.1 Aavishkar Company Information
13.18.2 Aavishkar Orally Dissolving Film Drug Product Offered
13.18.3 Aavishkar Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Aavishkar Main Business Overview
13.18.5 Aavishkar Latest Developments
13.19 IntelGenx Corp
13.19.1 IntelGenx Corp Company Information
13.19.2 IntelGenx Corp Orally Dissolving Film Drug Product Offered
13.19.3 IntelGenx Corp Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 IntelGenx Corp Main Business Overview
13.19.5 IntelGenx Corp Latest Developments
13.20 APR
13.20.1 APR Company Information
13.20.2 APR Orally Dissolving Film Drug Product Offered
13.20.3 APR Orally Dissolving Film Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 APR Main Business Overview
13.20.5 APR Latest Developments
14 Research Findings and Conclusion